biotech
Novartis To Build Cell-Culture Based Flu Vaccines Plant in US
Filed in archive Biotech Hubs and Facilities , Corporate and Industrial News , Diagnostics, Methodologies and Instrumentation , Drugs, Vaccines and Therapeutics by ruth on July 19, 2006
BlogPicture
Novartis will build a $600 million plant in the United States to develop flu vaccines using advanced, cell-culture techniques. The facility would be based in holly Springs, North Carolina, and construction is expected to begin in 2007. Once operational, the plant is expected to manufacture up to 50 million doses of seasonal trivalent flu vaccines, which will be for use in the United States.

Part of this investment includes the $220 million grant Novartis received from the US Department of Health and Human Services in May, 2006.

More from AlertNet/Reuters.

Permalink: Novartis To Build Cell-Culture Based Flu Vaccines Plant in US
Tags: vaccine  flu  biotech  vaccines  cell  cell+culture  novartis+build  based+vaccines 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/29660
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Novartis To Build Cell-Culture Based Flu Vaccines Plant in US:

  • Currently 8.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.00 out of 4 vote(s) cast.
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!